Literature DB >> 14961006

GDNF gene therapy attenuates retinal ischemic injuries in rats.

Wei-Chi Wu1, Chi-Chun Lai, Show-Li Chen, Ming-Hui Sun, Xiao Xiao, Tun-Lu Chen, Ray Jui-Fang Tsai, Shu-Wen Kuo, Yeou-Ping Tsao.   

Abstract

PURPOSE: To examine the protective effects of glial cell line-derived neurotrophic factor (GDNF) on retinal ischemia-reperfusion injury by using gene delivery.
METHODS: Gene delivery to retinal cells was achieved through intravitreal injections of recombinant adeno-associated virus expressing GDNF (rAAV-GDNF) in the right eyes and AAV expressing Escherichia coli LacZ (rAAV-LacZ) in the left eyes of Sprague-Dawley rats. Ischemic injury was introduced three weeks after gene delivery. The synthesis and accumulation of GDNF within the retina were determined using immunohistochemistry and enzyme-linked immunosorbent assay (ELISA) three weeks after gene delivery. The neuroprotective effects of GDNF were evaluated by determining the preservation of the inner retina thickness and the cell counts in the retinal ganglion cell (RGC) layer one week after reperfusion. In addition, eletroretinograms (ERGs) were performed to determine the functionality of the retinas. Finally, the levels of RGC apoptosis were measured using the TdT-dUTP terminal nick-end labeling (TUNEL) method 6 h after reperfusion.
RESULTS: Gene expression of GDNF was demonstrated through immunohistochemistry and ELISA. Thinning of the inner retina and decreased numbers of cells in RGC layer were noted after ischemia in all of the eyes. However, the thickness of the inner retina and the numbers of cells in RGC layer were better preserved in rAAV-GDNF treated eyes than in rAAV-LacZ treated eyes seven days after reperfusion (p=0.028 and p<0.001, respectively). Also, seven days after reperfusion, the rAAV-GDNF treated eyes had retained larger b-wave amplitudes than rAAV-LacZ treated eyes (p=0.003). Finally, rAAV-GDNF treated eyes had statistically fewer apoptotic cells in the RGC layer than the control eyes (p=0.011).
CONCLUSIONS: In these experiments, GDNF moderately protected rat retina from ischemia-reperfusion injury, possibly by preventing apoptosis in retinal cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14961006

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  14 in total

1.  Effects of intravitreal ropivacaine on retinal thickness and integrity in the guinea pig.

Authors:  Gonul Olmez; Sevin Soker Cakmak; Sevda Ipek Soker; Yusuf Nergiz; Fethin Yildiz
Journal:  Curr Ther Res Clin Exp       Date:  2005-07

2.  POD nanoparticles expressing GDNF provide structural and functional rescue of light-induced retinal degeneration in an adult mouse.

Authors:  Sarah P Read; Siobhan M Cashman; Rajendra Kumar-Singh
Journal:  Mol Ther       Date:  2010-08-10       Impact factor: 11.454

Review 3.  What can we learn about stroke from retinal ischemia models?

Authors:  Philippe M D'Onofrio; Paulo D Koeberle
Journal:  Acta Pharmacol Sin       Date:  2012-12-03       Impact factor: 6.150

4.  Paradoxical role of BDNF: BDNF+/- retinas are protected against light damage-mediated stress.

Authors:  R Brooks Wilson; Kannan Kunchithapautham; Bärbel Rohrer
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-06       Impact factor: 4.799

5.  Cell-specific gene therapy driven by an optimized hypoxia-regulated vector reduces choroidal neovascularization.

Authors:  Manas R Biswal; Howard M Prentice; George W Smith; Ping Zhu; Yao Tong; C Kathleen Dorey; Alfred S Lewin; Janet C Blanks
Journal:  J Mol Med (Berl)       Date:  2018-08-13       Impact factor: 4.599

6.  Preclinical models to investigate retinal ischemia: advances and drawbacks.

Authors:  Gillipsie Minhas; Ryuichi Morishita; Akshay Anand
Journal:  Front Neurol       Date:  2012-05-11       Impact factor: 4.003

7.  Reduction of experimental diabetic vascular leakage by delivery of angiostatin with a recombinant adeno-associated virus vector.

Authors:  Mong-Ping Shyong; Fenq-Lih Lee; Ping-Chang Kuo; Ai-Ching Wu; Huey-Chung Cheng; Show-Li Chen; Tao-Hsin Tung; Yeou-Ping Tsao
Journal:  Mol Vis       Date:  2007-01-31       Impact factor: 2.367

8.  Experimental effect of retinoic acids on apoptosis during the development of diabetic retinopathy.

Authors:  Nami Nishikiori; Makoto Osanai; Hideki Chiba; Takashi Kojima; Shuichiro Inatomi; Hiroshi Ohguro; Norimasa Sawada
Journal:  Clin Ophthalmol       Date:  2008-03

9.  Protection of visual functions by human neural progenitors in a rat model of retinal disease.

Authors:  David M Gamm; Shaomei Wang; Bin Lu; Sergei Girman; Toby Holmes; Nicholas Bischoff; Rebecca L Shearer; Yves Sauvé; Elizabeth Capowski; Clive N Svendsen; Raymond D Lund
Journal:  PLoS One       Date:  2007-03-28       Impact factor: 3.240

10.  Suppression of experimental uveitis by a recombinant adeno-associated virus vector encoding interleukin-1 receptor antagonist.

Authors:  Ming-Ling Tsai; Chi-Ting Horng; Show-Li Chen; Xiao Xiao; Chih-Hung Wang; Yeou-Ping Tsao
Journal:  Mol Vis       Date:  2009-08-08       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.